AbFero Announces PK Study Results for SP-420 in Transfusional Iron Overload – Proceeds With Phase 1–2 Trial of Iron Chelator
UF startup AbFero Pharmaceuticals, Inc., a privately-held clinical-stage pharmaceutical company dedicated to treating diseases of iron overload, announced it completed analysis of a 12-patient normal... Read More